Galera Therapeutics, Inc. Common Stock
GRTX
GRTX was delisted on the 3rd of June, 2024.
44 hedge funds and large institutions have $50.6M invested in Galera Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 14 closing their positions.
385% more call options, than puts
Call options by funds: $3.76M | Put options by funds: $775K
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
10% more funds holding
Funds holding: 40 → 44 (+4)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
69% less capital invested
Capital invested by funds: $162M → $50.6M (-$111M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$868K |
| 2 |
Morgan Stanley
New York
|
+$611K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$483K |
| 4 |
Millennium Management
New York
|
+$387K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$358K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$35.3M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$16.5M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.2M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$4.6M |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$3.83M |
GRTX Hedge Fund Activity: Q4 2021 in Review
44 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q4 2021, worth a combined $50.6M — down 69% from $162M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new GRTX positions and 14 closed out — a net gain of 4 holders — while 8 added to existing stakes and 10 trimmed.
The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $868K. The largest seller was NEA Management Company, exiting entirely with an estimated $35.3M sold.
- 44 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q4 2021, up from 40 in Q3 2021.
- Funds reported $50.6M of Galera Therapeutics, Inc. Common Stock stock for Q4 2021, down 69% quarter-over-quarter.
- 18 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q4 2021 and 14 closed out, a net change of +4 holders.
- The largest Galera Therapeutics, Inc. Common Stock buyer in Q4 2021 was Acuta Capital Partners, an estimated $868K added.
- The largest Galera Therapeutics, Inc. Common Stock seller in Q4 2021 was NEA Management Company, an estimated $35.3M sold.
Based on aggregated 13F filings for Q4 2021.